Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
808 JPY | -0.37% | -1.94% | -31.06% |
Mar. 21 | US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak | MT |
Mar. 21 | JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion | MT |
Sales 2024 * | 45.37B 293M | Sales 2025 * | 41.75B 270M | Capitalization | 101B 651M |
---|---|---|---|---|---|
Net income 2024 * | 7.24B 46.8M | Net income 2025 * | 6.28B 40.59M | EV / Sales 2024 * | 2.5 x |
Net Debt 2024 * | 12.66B 81.78M | Net Debt 2025 * | 9B 58.11M | EV / Sales 2025 * | 2.63 x |
P/E ratio 2024 * |
13.9
x | P/E ratio 2025 * |
16
x | Employees | 879 |
Yield 2024 * |
2.42% | Yield 2025 * |
2.48% | Free-Float | 52.97% |
1 day | -0.37% | ||
1 week | -1.94% | ||
Current month | -5.94% | ||
1 month | -9.82% | ||
3 months | -30.40% | ||
6 months | -27.57% | ||
Current year | -31.06% |
Managers | Title | Age | Since |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 45 | 03-03-31 |
Yutaka Honda
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Toshihide Yoda
BRD | Director/Board Member | 61 | 18-06-26 |
Philippe Fauchet
BRD | Director/Board Member | 65 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.67% | 23 M€ | +0.76% | - | |
0.30% | 15 M€ | +6.12% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 808 | -0.37% | 516 800 |
24-04-22 | 811 | +3.84% | 574,400 |
24-04-19 | 781 | -2.25% | 682,500 |
24-04-18 | 799 | -0.25% | 344,300 |
24-04-17 | 801 | -2.91% | 331,700 |
Delayed Quote Japan Exchange, April 23, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.06% | 654M | |
+27.22% | 659B | |
+27.68% | 557B | |
-4.49% | 359B | |
+16.39% | 322B | |
+9.45% | 297B | |
+6.30% | 215B | |
+4.80% | 210B | |
-6.05% | 200B | |
-8.93% | 149B |
- Stock Market
- Equities
- 4552 Stock